Condition

Pancreatic Cancer, Adult

ClinicalTrials.gov condition label

Clinical trials4

Recruiting2

Common interventions7

Lead sponsors shown4

Clinical trials

4 shown

The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic ProfilingNCT06717295 · 2025-12-20

RECRUITING

Surveillance of Pancreatic Health After Diabetes DiagnosisNCT06803771 · 2025-05-21

RECRUITING

FAPI PET Imaging - An Exploratory StudyNCT07705074 · 2026-08-01

NOT_YET_RECRUITING

Relation Between Cachexia, Diabetes and periNeural Invasion in PANcreatic Cancer- Biomarkers SubstudyNCT03042442 · 2017-01-01

COMPLETED

Common interventions

[18F]FAPI-74 PET/CTDRUG1Avantect Pancreatic Cancer TestDEVICE1Clinical, venous blood samples, pancreatic tissueOTHER1DiNanoQ: A multi-cancer early detection (MCED) blood testDIAGNOSTIC_TEST1DiNanoTrack: Therapeutic Response Monitoring Blood TestOTHER1Follow-upOTHER1Point-of care biomarkersDIAGNOSTIC_TEST1

Leading sponsors

Iuliu Hatieganu University of Medicine and Pharmacy1Javier Toledo1Martin Huellner1University Hospital Southampton NHS Foundation Trust1

Trial status mix

RECRUITING2

COMPLETED1

NOT_YET_RECRUITING1

Phase mix

NA1

PHASE11

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.